Few people know that in only one out of three cancer patients benefit from first line anti-cancer therapy. This is because every tumor is unique and thus knowing which therapy would work best in an individual patient remains a major challenge for oncologists. SageMedic is working feverishly on a test of the patient’s biopsy to guide oncologists in picking the most effective treatment to double their chance of tumor response, quality of life, and life expectancy.
Location: United States, California, Redwood City
Investors 4
| Date | Name | Website |
| 17.05.2025 | Cowtown An... | cowtownang... |
| - | MBC BioLab... | mbcbiolabs... |
| - | Keiretsu F... | keiretsufo... |
| - | K2X | k2x.capita... |